Table 1 Characteristics of CLL subjects
From: GIFT4 fusokine converts leukemic B cells into immune helper cells
| CLL subject number | Gender | Age |
CD5+CD19+ CLL cells in PBMC (%) |
|---|---|---|---|
| 1 | M | 78 | 93.2 |
| 2 | F | 74 | 87.6 |
| 3 | M | 64 | 93.8 |
| 4 | M | 57 | 81.6 |
| 5 | M | 72 | 86.1 |
| 6 | M | 38 | 84.2 |
| 7 | F | 56 | 95.6 |
| 8 | F | 75 | 82.6 |
| 9 | F | 52 | 81.0 |
| 10 | F | 76 | 87.4 |
| 11 | M | 54 | 94.7 |
| 12 | M | 62 | 86.0 |
